PubMed COVID-19 Clinical Care

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

Antiviral discovery in toxic cyanobacteria: Low hanging fruit in the age of pandemics

Thursday, January 04, 2024 - 4:00 AM

The power of novel vaccination technologies and their rapid development were elucidated clearly during the COVID-19 pandemic. At the same time, it also became clear that there is an urgent need to discover and manufacture new antivirals that target

A novel assay based on DNA melting temperature for multiplexed identification of SARS-CoV-2 and influenza A/B viruses

Thursday, January 04, 2024 - 4:00 AM

CONCLUSION: The newly developed assay offers a straightforward, cost-effective and nucleic acid contamination-free approach for simultaneous detection of the SARS-CoV-2, influenza A, and influenza B viruses. The method offers high analytical

A virtual intergenerational befriending intervention reduces Social Isolation in Older Adults and improves students' attitude towards companionship: A Qualitative Study

Thursday, January 04, 2024 - 4:00 AM

CONCLUSIONS: The virtual intergenerational intervention to befriending reduced boredom and loneliness in older adults and enhanced positive attitude and confidence in university students. Students helped older adults to develop digital skills on the

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey

Thursday, January 04, 2024 - 4:00 AM

CONCLUSION: Insomnia with depression increased during COVID-19. The patients were younger than before the epidemic, and a higher proportion with insomnia for >2 years had depression. The proportion of patients with insomnia with anxiety and